FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

37665511000001108: Forxiga 10mg tablets (Ethigen Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1422521000001119 Forxiga 10mg tablets (Ethigen Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1422541000001112 Forxiga 10mg tablets (Ethigen Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Forxiga 10mg tablets (Ethigen Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Is a Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Is a Forxiga true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Is a Dapagliflozin 10mg tablets true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Is a Dapagliflozin 10mg tablets false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Forxiga 10mg tablets (Ethigen Ltd) 28 tablet Has AMP True Forxiga 10mg tablets (Ethigen Ltd) Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Ethigen Ltd) 30 tablet Has AMP True Forxiga 10mg tablets (Ethigen Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start